Labib H, Shirinskiy I J, Roelofs J J T H, van der Voorn J P, van Schuppen J, Oosterlaan J, van Heurn L W E, Benninga M A, Derikx J P M
Amsterdam UMC Location University of Amsterdam, Department of Pediatric Surgery, Meibergdreef 9, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology and Metabolism Research Institute, Amsterdam, The Netherlands; Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.
Amsterdam UMC Location University of Amsterdam, Department of Pediatric Surgery, Meibergdreef 9, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology and Metabolism Research Institute, Amsterdam, The Netherlands; Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.
J Pediatr Surg. 2025 Mar;60(3):162066. doi: 10.1016/j.jpedsurg.2024.162066. Epub 2024 Nov 13.
It is challenging to distinguish between patients with Hirschsprung disease (HD) and patients with other causes of defecation problems based on clinical presentation in patients older than six months. Pathological examination of the rectal biopsy is the gold standard for the diagnosis of HD. The aim of this study was to gain insight into 1) the prevalence and severity of complications following rectal biopsy, 2) the final diagnoses of patients referred for biopsy, and 3) clinical factors associated with HD in patients older than six months.
Children suspected of HD above the age of six months referred for biopsies were analyzed retrospectively. Severity of complications of rectal suction biopsy (RSB) and full thickness biopsy (FTB) were assessed using Clavien-Madadi (CM) grading. Factors associated with HD were tested using multivariate logistic regression analysis.
From 2000 to 2022, 234 children older than six months of age underwent biopsies because of defecation problems (median age of 47.2 months (IQR = 17.2-87.2)). Of these, 130 out of 234 children underwent RSB and 112 out of 234 children underwent FTB. One patient (0.4 %) developed a complication following RSB (CM1-A): fever without evident cause. Two patients (0.9 %) had ongoing rectal bleeding following FTB. One patient did not require an intervention (CM1-A), the other received rectal spongostan to stop the bleeding and erythrocyte transfusion (CM2). The most frequent final diagnoses were functional constipation (n = 179, 76.5 %), HD (n = 25, 10.6 %) and food intolerance (n = 5, 2.1 %). Associated factors for HD were distended abdomen (OR 5.41, CI 2.05-14.31), vomiting (OR 4.14, CI 1.64-11.85) and no abdominal pain (OR 0.14, CI 0.03-0.65) (model R = 0.278).
In children older than six months suspected of HD, presenting with distended abdomen, vomiting and no abdominal pain, we advise obtaining a rectal biopsy in case other causes of constipation are ruled out, because a rectal biopsy is a safe procedure with only minor complications. The most common diagnosis in patients older than six months of age referred for rectal biopsy was functional constipation.
Level III.
对于6个月以上因排便问题就诊的患者,仅根据临床表现区分先天性巨结肠(HD)患者和其他原因导致排便问题的患者具有挑战性。直肠活检的病理检查是HD诊断的金标准。本研究的目的是深入了解:1)直肠活检后并发症的发生率和严重程度;2)接受活检患者的最终诊断结果;3)6个月以上HD患者的临床相关因素。
对6个月以上疑似HD并接受活检的儿童进行回顾性分析。采用Clavien-Madadi(CM)分级评估直肠吸引活检(RSB)和全层活检(FTB)并发症的严重程度。采用多因素逻辑回归分析HD的相关因素。
2000年至2022年,234名6个月以上儿童因排便问题接受活检(中位年龄47.2个月(IQR=17.2-87.2))。其中,234名儿童中有130名接受了RSB,234名儿童中有112名接受了FTB。1例患者(0.4%)RSB后出现并发症(CM1-A级):不明原因发热。2例患者(0.9%)FTB后持续直肠出血。1例患者无需干预(CM1-A级),另1例接受直肠海绵压迫止血及红细胞输注(CM2级)。最常见的最终诊断为功能性便秘(n=179,76.5%)、HD(n=25,10.6%)和食物不耐受(n=5,2.1%)。HD的相关因素为腹胀(OR 5.41,CI 2.05-14.31)、呕吐(OR 4.14,CI 1.64-ll.85)和无腹痛(OR 0.14,CI 0.03-0.65)(模型R=0.278)。
对于6个月以上疑似HD且伴有腹胀、呕吐和无腹痛的儿童,在排除其他便秘原因后,建议进行直肠活检,因为直肠活检是一种安全的操作,并发症较少。6个月以上因排便问题接受直肠活检的患者最常见诊断为功能性便秘。
III级。